Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2020 Filed Feb 27, 2020 23:44 UTC |
Lee EstherEVP - Gl. Chief Marketing Off.
|
GrantRestricted Stock Units · Derivative | 3,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,941 Underlying: Common Stock · 3,941 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:44 UTC |
Lee EstherEVP - Gl. Chief Marketing Off.
|
GrantEmployee Stock Options (right to buy) · Derivative | 11,823 | $0.00 Strike: $47.58 | $0.00 |
DisclosureSEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,823 Underlying: Common Stock · 11,823 shares Expires 2030-02-24 F3 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:44 UTC |
Lee EstherEVP - Gl. Chief Marketing Off.
|
Tax withholdingCommon Stock | 249 | $47.58 | $11,847.42 |
DisclosureSEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,446 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the deferred shares. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:44 UTC |
Lee EstherEVP - Gl. Chief Marketing Off.
|
GrantCommon Stock | 9,755 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,695 F1 · price: Shares earned from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. The reporting person deferred these shares under the MetLife Leadership Deferred Compensation Plan, which allows eligible employees to defer receipt of such shares for a specific period of time. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:43 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantRestricted Stock Units · Derivative | 12,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000092 · wf-form4_158284700404502.xml · derivative · entry 4 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,611 Underlying: Common Stock · 12,611 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:43 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 37,832 | $0.00 Strike: $47.58 | $0.00 |
DisclosureSEC source: 0001099219-20-000092 · wf-form4_158284700404502.xml · derivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,832 Underlying: Common Stock · 37,832 shares Expires 2030-02-24 F3 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:43 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Tax withholdingCommon Stock | 10,095 | $47.58 | $480,320.10 |
DisclosureSEC source: 0001099219-20-000092 · wf-form4_158284700404502.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,222 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:43 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantCommon Stock | 24,387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000092 · wf-form4_158284700404502.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,317 F1 · price: Shares acquired from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:43 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantRestricted Stock Units · Derivative | 4,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000091 · wf-form4_158284698252435.xml · derivative · entry 4 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256 Underlying: Common Stock · 4,256 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:43 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantEmployee Stock Options (right to buy) · Derivative | 12,768 | $0.00 Strike: $47.58 | $0.00 |
DisclosureSEC source: 0001099219-20-000091 · wf-form4_158284698252435.xml · derivative · entry 3 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,768 Underlying: Common Stock · 12,768 shares Expires 2030-02-24 F3 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:43 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
Tax withholdingCommon Stock | 1,219 | $47.58 | $58,000.02 |
DisclosureSEC source: 0001099219-20-000091 · wf-form4_158284698252435.xml · nonDerivative · entry 2 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,382 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:43 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantCommon Stock | 3,122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000091 · wf-form4_158284698252435.xml · nonDerivative · entry 1 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,601 F1 · price: Shares acquired from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:41 UTC |
Khalaf MichelDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 31,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000089 · wf-form4_158284688023809.xml · derivative · entry 4 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,526 Underlying: Common Stock · 31,526 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. F4 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:41 UTC |
Khalaf MichelDirector · President & CEO
|
GrantEmployee Stock Options (right to buy) · Derivative | 94,578 | $0.00 Strike: $47.58 | $0.00 |
DisclosureSEC source: 0001099219-20-000089 · wf-form4_158284688023809.xml · derivative · entry 3 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,578 Underlying: Common Stock · 94,578 shares Expires 2030-02-24 F2 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:41 UTC |
Khalaf MichelDirector · President & CEO
|
Disposition to issuerCommon Stock | 17,558 | $47.58 | $835,409.64 |
DisclosureSEC source: 0001099219-20-000089 · wf-form4_158284688023809.xml · nonDerivative · entry 2 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,580 F1 · kind: Cash payout of 2017-2019 performance units, following determination of the performance factor for such award. Each performance unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:41 UTC |
Khalaf MichelDirector · President & CEO
|
GrantCommon Stock | 17,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000089 · wf-form4_158284688023809.xml · nonDerivative · entry 1 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,138 F1 · price: Cash payout of 2017-2019 performance units, following determination of the performance factor for such award. Each performance unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:42 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantRestricted Stock Units · Derivative | 4,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,414 Underlying: Common Stock · 4,414 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:42 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 13,241 | $0.00 Strike: $47.58 | $0.00 |
DisclosureSEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,241 Underlying: Common Stock · 13,241 shares Expires 2030-02-24 F3 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:42 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Tax withholdingCommon Stock | 2,221 | $47.58 | $105,675.18 |
DisclosureSEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,322 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:42 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantCommon Stock | 6,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,543 F1 · price: Shares acquired from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:17 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 19,141 | $0.00 Strike: $31.13 | $0.00 |
DisclosureSEC source: 0001099219-20-000055 · wf-form4_158155303145185.xml · derivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,141 shares Expires 2020-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 23, 2011, 2012 and 2013. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:17 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
SaleCommon Stock | 14,200 | $51.60 | $732,649.00 |
DisclosureSEC source: 0001099219-20-000055 · wf-form4_158155303145185.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,930 F1 · shares: The Reporting Person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on February 10, 2020 and related tax obligations and fees. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:17 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionCommon Stock | 19,141 | $31.13 | $595,859.33 |
DisclosureSEC source: 0001099219-20-000055 · wf-form4_158155303145185.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:17 UTC |
SCHMIDT OSCARPresident, Latin America
|
Exercise / conversionUnit Options (Cash-Payable) · Derivative | 30,558 | $0.00 Strike: $40.91 | $0.00 |
DisclosureSEC source: 0001099219-20-000056 · wf-form4_158155305494390.xml · derivative · entry 3 SCHMIDT OSCAR · CIK 0001738204 · President, Latin America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,558 shares Expires 2021-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The unit options became exercisable in three equal installments on February 23, 2012, 2013 and 2014. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:17 UTC |
SCHMIDT OSCARPresident, Latin America
|
Disposition to issuerCommon Stock | 30,558 | $51.66 | $1,578,595.72 |
DisclosureSEC source: 0001099219-20-000056 · wf-form4_158155305494390.xml · nonDerivative · entry 2 SCHMIDT OSCAR · CIK 0001738204 · President, Latin America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Exercise of unit options, which are cash-payable stock appreciation rights. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:17 UTC |
SCHMIDT OSCARPresident, Latin America
|
Exercise / conversionCommon Stock | 30,558 | $40.91 | $1,250,127.78 |
DisclosureSEC source: 0001099219-20-000056 · wf-form4_158155305494390.xml · nonDerivative · entry 1 SCHMIDT OSCAR · CIK 0001738204 · President, Latin America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of unit options, which are cash-payable stock appreciation rights. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:49 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000042 · wf-form4_157834736962384.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,554 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:50 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000045 · wf-form4_157834743659746.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,777 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:51 UTC |
WEINBERGER MARK ADirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000048 · wf-form4_157834749967861.xml · nonDerivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,786 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:51 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000047 · wf-form4_157834747874883.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,696 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:51 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000046 · wf-form4_157834745741825.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,579 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:50 UTC |
Kennard William EDirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000043 · wf-form4_157834739107436.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,484 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:50 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000044 · wf-form4_157834741534870.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,669 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:49 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 1,332 | $51.62 | $68,757.84 |
DisclosureSEC source: 0001099219-20-000041 · wf-form4_157834734668706.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,182 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees and 50% of Board Chair retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:49 UTC |
Herzog David LDirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000040 · wf-form4_157834732576594.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,908 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:48 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000038 · wf-form4_157834728107694.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,730 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:48 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000039 · wf-form4_157834730240030.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,930 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:47 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000037 · wf-form4_157834725674088.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,300 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 21:19 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 6,716 | $0.00 Strike: $31.13 | $0.00 |
DisclosureSEC source: 0001099219-19-000270 · wf-form4_157739517975205.xml · derivative · entry 3 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,716 shares Expires 2020-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 23, 2011, 2012 and 2013. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 21:19 UTC |
McCallion John D.EVP & Chief Financial Officer
|
SaleCommon Stock | 5,378 | $51.17 | $275,176.13 |
DisclosureSEC source: 0001099219-19-000270 · wf-form4_157739517975205.xml · nonDerivative · entry 2 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,263 F1 · shares: The Reporting Person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 23, 2019 and related tax obligations and fees. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 21:19 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 6,716 | $31.13 | $209,069.08 |
DisclosureSEC source: 0001099219-19-000270 · wf-form4_157739517975205.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 22:00 UTC |
KILTS JAMES MDirector
|
OtherDeferred Share Equivalents · Derivative | 11,917 | $50.48 | $601,570.16 |
DisclosureSEC source: 0001099219-19-000261 · wf-form4_157662001951650.xml · derivative · entry 4 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,917 shares Expires not disclosed F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F5 · kind: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities. F5 · price: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities. F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 21:53 UTC |
HUBBARD ROBERT GLENNDirector
|
OtherDeferred Share Equivalents · Derivative | 24,485 | $50.48 | $1,236,002.80 |
DisclosureSEC source: 0001099219-19-000255 · wf-form4_157661956722583.xml · derivative · entry 3 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,485 shares Expires not disclosed F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities. F4 · price: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities. F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 21:47 UTC |
HASSELL GERALD LDirector
|
OtherDeferred Share Equivalents · Derivative | 2,469 | $50.48 | $124,635.12 |
DisclosureSEC source: 0001099219-19-000251 · wf-form4_157661921710346.xml · derivative · entry 3 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,469 shares Expires not disclosed F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities. F4 · price: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities. F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:10 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 33 | $50.38 | $1,662.54 |
DisclosureSEC source: 0001099219-19-000267 · wf-form4_157662060261576.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,852 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:07 UTC |
Lee EstherEVP & Chief Marketing Officer
|
GrantCommon Stock | 111 | $50.38 | $5,592.18 |
DisclosureSEC source: 0001099219-19-000265 · wf-form4_157662041646747.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,940 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:00 UTC |
KILTS JAMES MDirector
|
GrantDeferred Share Equivalents · Derivative | 103 | $50.38 | $5,189.14 |
DisclosureSEC source: 0001099219-19-000261 · wf-form4_157662001951650.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,917 Underlying: Common Stock · 103 shares Expires not disclosed F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F4 · timeliness: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:00 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 485 | $50.38 | $24,434.30 |
DisclosureSEC source: 0001099219-19-000261 · wf-form4_157662001951650.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,942 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:04 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 274 | $50.38 | $13,804.12 |
DisclosureSEC source: 0001099219-19-000263 · wf-form4_157662024285925.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,050 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 21:57 UTC |
Kennard William EDirector
|
GrantCommon Stock | 188 | $50.38 | $9,471.44 |
DisclosureSEC source: 0001099219-19-000259 · wf-form4_157661985493355.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,757 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.